Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia

Schizophrenia Research

Volumn 68, Issue 1, 2004, Pages 49-63

  Hill, S Kristian ^a   Schuepbach, Daniel ^b   Herbener, Ellen S ^a   Keshavan, Matcheri S ^c   Sweeney, John A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Longitudinal; Neurodevelopment; Neuropsychology; Schizophrenia

Indexed keywords

BENZATROPINE MESILATE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE; TREATMENT OUTCOME; VERBAL MEMORY; VISION; VISUAL MEMORY;

ADULT; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 1642417691     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00213-5     Document Type: Article

References (77)

1. Abrahamson D. Schizophrenic deterioration. Br. J. Psychiatry. 143:1983;82-83.
2. American Psychiatric Association Diagnostic and Statistical Manual. 3rd ed., revised/4th ed. 1987/1994;APA, Washington, DC.
3. Andreasen N.C. Scale for the Assessment of Negative Symptoms. 1984;University of Iowa Press, Iowa City, IA.
4. Andreasen N.C. Scale for the Assessment of Positive Symptoms. 1984;University of Iowa Press, Iowa City, IA.
5. Baum K.M., Walker E.F. Childhood patterns of adult symptom dimensions in schizophrenia. Schizophr. Res. 16:1995;111-120.
6. Benton A.L., Hamsher K. Multilingual Aphasia Examination. 1976;University of Iowa, Iowa City, IA.
7. Bilder R.M. Neurocognitive impairments in schizophrenia and how it affects treatment options. Can. J. Psychiatry. 42:1997;255-264.
8. Bilder R.M., Lipschutz-Broch L., Reiter G., Geisler S.H., Mayerhoff D.I., Lieberman J.A. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr. Res. 18:1992;437-448.
9. Bilder R.M., Bogerts B., Ashtari W., Wu H., Alvir J.M., Jody D., Reiter G., Bell L., Lieberman J.A. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr. Res. 17:1995;47-58.
10. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., Pappadopulos E., Willson D.F., Alvir J.M., Woerner M.G., Geisler S., Kane J.M., Lieberman J.A. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry. 157:2000;549-559.
11. Bilder R.M., Goldman R.S., Volavka J., Czobor P., Hoptman M., Sheitman B., Lindenmayer J., Citrome L., McEvoy J., Kunz M., Chakos M., Cooper T.B., Horowitz T.L., Lieberman J.A. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am. J. Psychiatry. 159:2002;1018-1028.
12. Bleuler E. Dementia Praecox or the Group of Schizophrenia. 1952;International Universities Press, New York.
13. Bustillo J.R., Thaker G., Buchanan R.W., Moran M., Kirkpatrick B., Carpenter W.T. Visual information-processing impairments in deficit and nondeficit schizophrenia. Am. J. Psychiatry. 154:1997;647-654.
14. Carpenter W.T., Gold J.M. Another view of therapy for cognition in schizophrenia. Biol. Psychiatry. 51:2002;969-971.
15. Cassens G., Inglis A.K., Appelbaum P.S., Gutheil T.G. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophr. Bull. 16:1990;477-499.
16. Censits D.M., Ragland J.D., Gur R.C., Gur R.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr. Res. 24:1997;289-298.
17. Chaikelson J.S., Schwartzman A.E. Cognitive changes with aging in schizophrenia. J. Clin. Psychol. 39:1983;25-30.
18. Cosway R., Byrne M., Clafferty R., Hodges A., Grant E., Abukmeil S.S., Lawrie S.M., Miller P., Johnstone E.C. Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh high risk study. Psychol. Med. 30:2000;1111-1121.
19. Cuesta M.J., Peralta V., Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr. Res. 48:2001;17-28.
20. Davidson M., Harvey P.D., Powchik P., Parrella M., White L., Knobler H.Y., Losonczy M.F., Keefe R.S.E., Katz S., Frecska E. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am. J. Psychiatry. 152:1995;197-207.
21. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California Verbal Learning Test (CVLT) Manual. 1983;The Psychological Corporation, New York, NY.
22. DeLisi L.E., Tew W., Xie S., Hoff A.L., Sakuma M., Kushner M., Lee G., Shedlack K., Smith A.M., Grimson R. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol. Psychiatry. 38:1995;349-360.
23. Gold S., Arndt S., Nopoulos P., O'Leary D.S., Andreasen N.C. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am. J. Psychiatry. 156:1999;1342-1348.
24. Goldberg T.E., Weinberger D.R., Berman K.F., Pliskin N.H., Podd M.H. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch. Gen. Psychiatry. 48:1987;1008-1014.
25. Goldberg T.E., Hyde T.M., Kleinman J.E., Weinberger D.R. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophr. Bull. 19:1993;797-804.
26. Green M.F., Marder S.R., Glynn S.M., McGurk S.R., Wirshing W.C., Wirshing D.A., Liberman R.P., Mintz J. The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol. Psychiatry. 51:2002;972-978.
27. Gur R.E., Chin S. Laterality in functional brain imaging studies of schizophrenia. Schizophr. Bull. 25:1999;141-156.
28. Harvey P.D., Moriarty P.J., Serper M.R., Schnur E., Lieber D. Practice-related improvement in information processing with novel antipsychotic treatment. Schizophr. Res. 46:2000;139-148.
29. Hawkins K.A., Wexler B.E. California verbal learning test practice effects in a schizophrenia sample. Schizophr. Res. 23:1999;73-78.
30. Heaton R.K. Wisconsin Card Sorting Test Manual. 1981;Psychological Assessment Resources, Odessa.
31. Heaton R.K., Crowley T.J. Effects of psychiatric disorders and their somatic treatments on neuropsychological test results. Filskov S.B., Boll T.J. Handbook of Clinical Neuropsychology. 1981;481-525 Wiley, New York.
32. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry. 58:2001;24-32.
33. Hedeker D., Gibbons R.D. Application of random-effects pattern mixture models for missing data in longitudinal studies. Psychol. Methods. 2:1997;64-78.
34. Hill S.K., Ragland J.D., Gur R.C., Gur R.E. Neuropsychological differences among empirically derived clinical subtypes of schizophrenia. Neuropsychology. 15:2001;492-501.
35. Hoff A.L., Sakuma M., Wieneke M., Horon R., Kushner M., DeLisi L.E. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am. J. Psychiatry. 156:1999;1336-1341.
36. Jastak S., Wilkinson G.S. The Wide Range Achievement Test - Revised Administration Manual. 1984;Jastak Associates, Wilmington, DE.
37. Keefe R.S.E., Perkins S., Silva S.M., Lieberman J.A. The effect of atypical antipsychotic drugs on neurocognitive function in schizophrenia. Schizophr. Bull. 25:1999;201-222.
38. King D.J. The effect of neuroleptics on cognitive and psychomotor function. Br. J. Psychiatry. 157:1990;799-811.
39. Kraepelin E. Dementia Praecox and Paraphrenia. 1925;Edinburgh, Livingston.
40. Kwon J.S., McCarley R.W., Hirayasu Y., Anderson J.E., Fischer I.A., Kikinis R., Jolesz F.A., Shenton M.E. Left planum temporale volume reduction in schizophrenia. Arch. Gen. Psychiatry. 56:1999;142-148.
41. Lieberman J.A. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia. J. Clin. Psychiatry. 60:1999;9-12.
42. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.J., Fischer I.A., Shenton M.E. MRI anatomy of schizophrenia. Biol. Psychiatry. 45:1999;1099-1119.
43. Medalia A., Gold J.M., Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics. Arch. Clin. Neuropsychol. 3:1988;249-271.
44. Mohamed S., Paulsen J.S., O'Leary D., Arndt S., Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch. Gen. Psychiatry. 56:1999;749-754.
45. Neumann C.S., Walker E.F. Childhood neuromotor soft signs, behavior problems and adult psychopathology. Adv. Clin. Child Psychol. 18:1996;173-203.
46. Nopoulos P., Flashman L., Flaum M., Arndt S., Andreasen N. Stability of cognitive functioning early in the course of schizophrenia. Schizophr. Res. 14:1994;29-37.
47. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 10:1962;799-812.
48. Park S. Hemispheric asymmetry of spatial working memory deficit in schizophrenia. Int. J. Psychophysiol. 34:1999;313-322.
49. Purdon S.E., Flor-Henry P. Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia. Schizophr. Res. 44:2000;221-232.
50. Purdon S.E., Jones B.D., Stip E., Labelle A., Addington D., David S.R., Breier A., Tollefson G.D. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. Arch. Gen. Psychiatry. 57:2000;249-258.
51. Purdon S.E., Woodward N.D., Flor-Henry P. Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia. J. Int. Neuropsychol. Soc. 7:2001;606-614.
52. Ragland J.D., Gur R.E., Klimas B.C., McGrady N., Gur R.C. Neuropsychological laterality indices of schizophrenia: interactions with gender. Schizophr. Bull. 25:1999;79-89.
53. Reitan R.M., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. 2nd ed. 1993;Neuropsychology Press, Tucson, AZ.
54. Rund B.J. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr. Bull. 24:1998;425-435.
55. Russell A.J., Munro J.C., Jones P.B., Hemsley D.R., Murray R.M. Schizophrenia and the myth of intellectual decline. Am. J. Psychiatry. 154:1997;635-639.
56. Saykin A.J., Gur R.C., Gur R.E., Mozley P.D., Mozley L.H., Resnick S.M., Kester B., Stafiniak P. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch. Gen. Psychiatry. 48:1991;618-624.
57. Saykin A.J., Shtasel D.L., Gur R.E., Kester D.B., Mozley L.H., Stafiniak P., Gur R.C. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry. 51:1994;124-131.
58. Schuepbach D., Keshavan M.S., Kmiec J.A., Sweeney J.A. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophr. Res. 53:2002;249-261.
59. Schuepbach, D., Hill, S.K., Sanders, R.D., Keshavan, M.S., Sweeney, J.A., in press. Early, treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naïve first episode schizophrenia: a two-year follow-up. Schizophr. Bull.
60. Seidman L.J., Pepple J.R., Faraone S.V., Kremen W.S., Green A.I., Brown W.A., Tsuang M.T. Biol. Psychiatry. 33:1993;575-584.
61. Silverberg-Shalev R., Gordon H.W., Bentin S., Aranson A. Selective language deterioration in chronic schizophrenia. J. Neurol. Neurosurg. Psychiatry. 44:1981;547-551.
62. Spitzer R.L., Williams J.B.W., Gibbons M., First M. Structured Clinical Interview for DSM-III-R (SCID). 1987;New York State Psychiatric Institute, New York.
63. Spohn H.E., Strauss M.E. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J. Abnorm. Psychology. 98:1989;367-380.
64. Stip E., Lussier I. The effect of risperidone on cognition in patients with schizophrenia. Can. J. Psychiatry. 41:1996;S35-S40.
65. Sumich A., Chitnis X.A., Fannon D.G., O'Ceallaigh S., Doku V.C., Falrowicz A., Marshall N., Matthew V.M., Potter M., Sharma T. Temporal lobe abnormalities in first-episode psychosis. Am. J. Psychiatry. 159:2002;1232-1235.
66. Sweeney J.A., Haas G.L., Keilp J.G., Long M. Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year follow-up study. Psychiatry Res. 38:1991;63-76.
67. Sweeney J.A., Haas G.L., Li S. Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia. Schizophr. Bull. 18:1992;283-293.
68. Tomer R., Flor-Henry P. Neuroleptics reverse attention asymmetries in schizophrenic patients. Biol. Psychiatry. 25:1989;852-860.
69. Velakouslis D., Pantelis C., McGorry P.D., Dudgeon P., Brewer W., Cook M., Desmond P., Bridle N., Tierney P., Murrie V., Singh B., Copolov D. Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch. Gen. Psychiatry. 56:1999;133-141.
70. Waddington J.L., Youssef H.A. Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol. Med. 26:1996;681-688.
71. Waddington J.L., Youssef H.A., Kinsella A. Cognitive dysfunction in schizophrenia followed-up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol. Med. 20:1990;835-842.
72. Walker E., Grimes K., Davis D., Smith A. Childhood precursors of schizophrenia: facial expressions of emotion. Am. J. Psychiatry. 150:1993;1654-1660.
73. Walker E.F., Savoie T., Davis D. Neuromotor precursors of schizophrenia. Schizophr. Bull. 20:1994;453-480.
74. Walker E., Lewine R., Neumann C. The relation between childhood behavioral characteristics and adult brain morphology in schizophrenia. Schizophr. Res. 22:1996;93-102.
75. Wechsler D.A. Wechsler Adult Intelligence Scale Revised (WAIS-R), Manual. 1981;The Psychological Corporation, Cleveland, OH.
76. Wechsler D.A. Wechsler Memory Scale Revised (WMS-R). 1987;The Psychological Corporation, Cleveland, OH.
77. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry. 155:1998;1661-1670.